Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity

Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis

(2014) Carmen Martínez et al.   PLoS One

Spondyloarthritis: may the force be with you?

(2013) Dennis McGonagle et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis

(2013) Raquel Almodóvar et al.   CLINICAL RHEUMATOLOGY

VIP Modulates IL-22R1 Expression and Prevents the Contribution of Rheumatoid Synovial Fibroblasts to IL-22-Mediated Joint Destruction

(2013) Mar Carrión et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

(2013) Daniel E. Furst et al.   RHEUMATOLOGY

Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis

(2013) Marina Amaral de Ávila Machado et al.   RHEUMATOLOGY INTERNATIONAL

The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study

(2012) U Kiltz et al.   ANNALS OF THE RHEUMATIC DISEASES

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor

(2012) Pedro Machado et al.   ANNALS OF THE RHEUMATIC DISEASES

Expression of synovial fluid and articular cartilage VIP in human osteoarthritic knee: A new indicator of disease severity?

(2012) Wei Jiang et al.   CLINICAL BIOCHEMISTRY

Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: Differences in early and late disease

(2012) Michael M. Ward et al.   ARTHRITIS CARE & RESEARCH

Predicting the outcome of ankylosing spondylitis therapy

(2011) N. Vastesaeger et al.   ANNALS OF THE RHEUMATIC DISEASES

2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis

(2011) D. van der Heijde et al.   ANNALS OF THE RHEUMATIC DISEASES

Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort

(2011) Ho Yin Chung et al.   ANNALS OF THE RHEUMATIC DISEASES

RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: Immune regulation by vasoactive intestinal peptide

(2011) Mar Carrión et al.   ARTHRITIS AND RHEUMATISM

Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis

(2011) Denis Poddubnyy et al.   ARTHRITIS AND RHEUMATISM

Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes

(2011) Laura NICCOLI et al.   International Journal of Rheumatic Diseases

Spondyloarthritis

(2011) Maxime Dougados et al.   LANCET

Assessment of work instability in spondyloarthritis: a cross-sectional study using the ankylosing spondylitis work instability scale

(2011) I. Fabreguet et al.   RHEUMATOLOGY

Soluble and Tissue Biomarkers in Ankylosing Spondylitis

(2010) Kurt de Vlam   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes

(2010) Rebeca Jimeno et al.   IMMUNOLOGY AND CELL BIOLOGY

The vasoactive intestinal polypeptide (VIP) levels at the patients with ankylosing spondylitis and its association with inflammation markers

(2010) Selim Nalbant et al.   RHEUMATOLOGY INTERNATIONAL

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondylarthritis

(2009) A. N. Bennett et al.   ARTHRITIS AND RHEUMATISM

From HLA-B27 to spondyloarthritis: a journey through the ER

(2009) Robert A. Colbert et al.   IMMUNOLOGICAL REVIEWS

Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence

(2008) H Marzo-Ortega et al.   ANNALS OF THE RHEUMATIC DISEASES

Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine

(2008) R Landewe et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: Implications for rheumatoid arthritis

(2007) Irene Gutiérrez-Cañas et al.   BRAIN BEHAVIOR AND IMMUNITY